insights_auto
Why is 4559 down 2,72%?
Dive Deeperchevron_right
4559:TYO
Zeria Pharmaceutical Co Ltd
1 898,00 JPY
arrow_downward
-2,72%(-53,00) 1D
2 ოქტ, 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
1 938 JPY
High
1 938 JPY
Low
1 895 JPY
Mkt. cap
95,13 მლრდ.
Avg. vol.
162,22 ათ.
Volume
240,70 ათ.
Dividend
2,58%
Quarterly dividend
12 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
10,17
52-wk high
2 434 JPY
52-wk low
1 878 JPY
EPS
187 JPY
Shares outstanding
50,11 მლნ.
No. of employees
2 ათ.
Open
1 938 JPY
High
1 938 JPY
Low
1 895 JPY
Mkt. cap
95,13 მლრდ.
Avg. vol.
162,22 ათ.
Volume
240,70 ათ.
Dividend
2,58%
Quarterly dividend
12 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
10,17
52-wk high
2 434 JPY
52-wk low
1 878 JPY
EPS
187 JPY
Shares outstanding
50,11 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
marketscreener.com
·
16 წუთის წინ
Vertical Aerospace Receives NYSE Noncompliance Notice
Business Wire
·
6 წუთის წინ
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Intellia Therapeutics
·
1 საათის წინ
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investor's Business Daily
·
16 წუთის წინ
Nasdaq Pops After Jobs Report; Arrow, Materion, Advantest In Focus
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 ათ.
Founded22 დეკ. 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp